Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Wichter

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Circulation|November 3, 2004
Abnormal myocardial presynaptic norepinephrine recycling in patients with Brugada syndromePeter Kies, Thomas Wichter, Michael Schäfers, et al.
Heart Rhythm|August 26, 2015
High interobserver variability in the assessment of epsilon waves: Implications for diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasiaPyotr G Platonov, Hugh Calkins, Richard N Hauer, et al.
Circulation|March 10, 2004
Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patientsThomas Wichter, Matthias Paul, Christian Wollmann, et al.
Circulation|October 13, 2006
Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient micePaulus Kirchhof, Larissa Fabritz, Melanie Zwiener, et al.
Heart Rhythm|October 17, 2012
Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathyDirk G Dechering, Simon Kochhäuser, Kristina Wasmer, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 13, 2004
Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failureMarkus Rothenburger, Thomas Wichter, Christof Schmid, et al.
American Journal of Human Genetics|December 23, 2006
Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathyArnd Heuser, Eva R Plovie, Patrick T Ellinor, et al.
Circulation|January 12, 2005
Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndromeLars Eckardt, Vincent Probst, Jeroen P P Smits, et al.
Heart (British Cardiac Society)|July 28, 2019
Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathyCéline Bégué, Stellan Mörner, Dulce Brito, et al.
Circulation|September 9, 2010
Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardiaDomenico Corrado, Hugh Calkins, Mark S Link, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Circulation|November 3, 2004
Abnormal myocardial presynaptic norepinephrine recycling in patients with Brugada syndromePeter Kies, Thomas Wichter, Michael Schäfers, et al.
Heart Rhythm|August 26, 2015
High interobserver variability in the assessment of epsilon waves: Implications for diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasiaPyotr G Platonov, Hugh Calkins, Richard N Hauer, et al.
Circulation|March 10, 2004
Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patientsThomas Wichter, Matthias Paul, Christian Wollmann, et al.
Circulation|October 13, 2006
Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient micePaulus Kirchhof, Larissa Fabritz, Melanie Zwiener, et al.
Heart Rhythm|October 17, 2012
Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathyDirk G Dechering, Simon Kochhäuser, Kristina Wasmer, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 13, 2004
Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failureMarkus Rothenburger, Thomas Wichter, Christof Schmid, et al.
American Journal of Human Genetics|December 23, 2006
Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathyArnd Heuser, Eva R Plovie, Patrick T Ellinor, et al.
Circulation|January 12, 2005
Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndromeLars Eckardt, Vincent Probst, Jeroen P P Smits, et al.
Heart (British Cardiac Society)|July 28, 2019
Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathyCéline Bégué, Stellan Mörner, Dulce Brito, et al.
Circulation|September 9, 2010
Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardiaDomenico Corrado, Hugh Calkins, Mark S Link, et al.
Pageof 10